Navigation Links
Cambrex Reschedules Third Quarter 2012 Financial Results and Earnings Call Date to November 5, 2012
Date:10/31/2012

EAST RUTHERFORD, N.J., Oct. 31, 2012 /PRNewswire/ --  Due to complications from the storm affecting the East Coast, Cambrex Corporation (NYSE: CBM, "Cambrex") will now report its results of the third quarter ended September 30, 2012 after the market closes Monday, November 5, 2012

The Company will also host a conference call to discuss the financial results Monday, November 5, 2012 at 4:45 p.m. EST.

 Third Quarter 2012 Earnings Conference Call When:  

Monday, November 5, 2012 at 4:45 p.m. Eastern Time Dial-in:  

1-888-430-8705 for U.S.1-719-325-2455 for International Passcode:  1704787Dial-in Replay:

1-888-203-1112 for U.S.1-719-457-0820 for InternationalPasscode:  1704787Available through Monday, November 12, 2012Webcast:www.cambrex.comAbout CambrexCambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.


'/>"/>
SOURCE Cambrex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cambrex Reports Second Quarter 2012 Results
2. Cambrex to Announce Fourth Quarter 2011 Financial Results on February 6, 2012
3. Life Technologies Reschedules Issuance Of Third Quarter 2012 Performance Report And Associated Conference Call And Webcast to Thursday, November 1, 2012 Due To Expected Severe Weather Conditions
4. InterMune To Release Third Quarter Financial Results On November 7
5. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
6. United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012
7. Anthera Pharmaceuticals Reports 2012 Third Quarter Financial Results And Provides Clinical Progress Update
8. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
9. Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
10. Origin Agritech Limited Reports Unaudited Third Quarter Financial Results For Three Months Ended June 30, 2012
11. Origin Agritech Limited to Announce FY2012 Third Quarter Financial Results on August 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... ... 20, 2017 , ... CNSDose is a genetically driven, clinically ... by finding the right antidepressant faster. CNSDose speeds recovery and reduces side ... personalized approach to treatment. , A peer-reviewed and published, 12-week double-blind ...
(Date:5/18/2017)... (PRWEB) , ... May 18, 2017 , ... ... procedure on April 28, 2017 at the Prince Of Wales Private Hospital. The ... disc at level C6-C7. The patient failed conservative treatments prior to undergoing surgery. ...
(Date:5/18/2017)... ... May 17, 2017 , ... NDA Partners Chairman Carl Peck, MD , ... Advantar Laboratories and President of Pharmaceutical Development Business Unit of Cardinal Health, has joined ... Cardinal Health, he was former Chief Operating Officer at Anaborex, Senior VP and General ...
(Date:5/18/2017)... BARBARA, CALIFORNIA (PRWEB) , ... May 17, 2017 ... ... management, technological innovation and business process optimization firm for the life sciences and ... Chairman of the UDIs and Traceability for Medical Devices conference in Brussels, Belgium. ...
Breaking Biology Technology:
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
Breaking Biology News(10 mins):